SB 350 – New Hampshire
Status: EnactedYear Introduced: 2018
Link: http://gencourt.state.nh.us/bill_status/bill_status.aspx?lsr=2758&sy=2018&sortoption=&txtsessionyear=2018&txtbillnumber=SB350
BIOLOGICAL PRODUCTS DISPENSED BY PHARMACISTS: A pharmacist shall substitute a biological product pursuant to this section only if it has been licensed by the federal Food and Drug Administration as an interchangeable biological product for the prescribed biological product. This bill amends RSA 318:47 to read that a “drug product” does not include a “biological product” for the purposes of this section.
Enacted at N.H. Rev. Stat. Ann. § 318:47-d, N.H. Rev. Stat. Ann. § 318:47-dd, N.H. Rev. Stat. Ann. § 126-A:77.
Key Issues:
PHARMACEUTICALS
Biosimilar or Generic Competition
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found
Leave A Comment